论文部分内容阅读
2001年1～2月,46家沪深两市 A 股上市公司进行了58例资产重组,分类特征不算很明显,但仍然颇多可圈可点、并具一定代表性的个案。上市公司投资科技产业看好,由科技类上市公司投资本行业的科技产业尤其看好。至少在决策环节上,这种重组有利于上市公司成长,产业结构优化、乃至于国民经济发展,在微观经济组织形式的层面上打下了良好的基础。如浙江医药与合作伙伴共同组建研发中心一例,就该案而言,来自科技产业的资金与科研力量、技术专家的合作才真正是新经济的希望所在,特别是专家自然人的加入,是该公司激励机制的一个很好基础。类似
From January to February 2001, 46 A-share listed companies in Shanghai and Shenzhen conducted 58 asset restructurings. The classification is not very clear, but there are still many remarkable and representative cases. Listed companies are optimistic about the investment in science and technology industry, science and technology listed companies to invest in the industry’s technology industry is particularly optimistic. At least in the decision-making process, this reorganization is conducive to the growth of listed companies, the optimization of industrial structure and even the development of the national economy, laying a good foundation for the formation of micro-economic organizations. For example, Zhejiang Pharmaceuticals and its partners jointly set up a R & D center. In this case, the cooperation between funds from scientific and technological industries, scientific research strength and technical experts is really the hope of the new economy. In particular, the joining of experts and natural persons is the reason why the company A good foundation for incentives. similar